A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Manufacturer of Suboxone Is Sued for Dental Side Effects


Suboxone, a medication used to treat opioid addiction, was approved for use by the United States Food and Drug Administration (FDA) in 2002. In 2022, the FDA issued a warning regarding Suboxone’s increased risk for dental side effects, citing more than 300 reports of dental caries in regular users. The warning came too late for one Ohio woman who began using Suboxone after becoming addicted to prescription pain medications. She is suing the manufacturer of Suboxone due to her development of serious tooth decay, which required extensive restorative dental treatment. The plaintiff claims that the pharmaceutical company knowingly started producing Suboxone in a dissolvable film form for under-the-tongue use to gain a competitive edge, despite being aware that this method significantly increased the risk of dental decay, all without informing healthcare providers or consumers. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy